InvestorsHub Logo
Followers 438
Posts 45331
Boards Moderated 4
Alias Born 05/11/2008

Re: None

Sunday, 08/15/2021 5:55:09 AM

Sunday, August 15, 2021 5:55:09 AM

Post# of 513
for new eyes a good point to start DD

https://temertymedicine.utoronto.ca/news/u-t-test-new-drug-covid-19-edesa-biotech



Impressive read about .DR. PAR NIJHAWAN

Dr. Par Nijhawan is a seasoned physician and entrepreneur with 20 years of experience in cross-functional roles including finance, marketing and business and drug development. Dr. Nijhawan is the Founder and CEO of Edesa Biotech. In addition, he is the Founder and Chairman of Exzell Pharma, ranked as Canada’s fastest growing company in 2019. Dr. Nijhawan was Founder and CEO of Medical Futures Inc., a specialty pharmaceutical company which he successfully sold to a public company in 2015. He also established Digestive Health Clinic, Canada’s largest provider of private endoscopy services. Dr. Nijhawan was inducted into the CHLA BD Hall of fame in 2018 and Awarded Business Development Deal of the Year 2017. Dr. Nijhawan received his MD (University of Ottawa), Internship (Yale), Residency IM (Mayo), Fellowship GI (Mayo)

https://www.prnewswire.com/news-releases/edesa-biotech-wins-chla-award-for-best-bd-deal-of-2017-and-dr-par-nijhawan-inducted-into-the-chla-hall-of-fame-675970213.html

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EDSA News